3 New Strong Buy Ratings from Top-Rated Analysts: 05/06/2026

Our gift to you: Here’s a no-paywall peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• Jones Lang LaSalle Inc (JLL) — Q1 earnings beat fuels 41% upside potential.
• Tenet Healthcare Corp (THC) — 12 analysts agree: massive 57% upside ahead.
• Brink's Co (BCO) — Armored truck giant eyes 96% earnings explosion.

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

1. Jones Lang LaSalle Inc (NYSE: JLL)

A $14.63B real estate powerhouse, Jones Lang LaSalle dominates agency leasing, capital markets advisory, and property management as the industry's top-rated player. Q1 2026 earnings just beat estimates — driven by leasing advisory growth, expanding margins, and strong momentum across every service line.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $318.13 — get current quote

Max 1-year forecast: $445.00

Here are 3 BIG reasons why we’re watching:

1. Strong analyst support: Right now, JLL enjoys 2 Strong Buy ratings, 1 Buy rating, and 1 Hold rating among 4 analysts, with a max price target that suggests roughly 40% potential upside in the coming year. That max forecast comes from UBS's Alex Kramm (a top 12% rated analyst), who cites robust growth in real estate services, increased demand across markets, and JLL's ability to leverage technology for competitive advantage. See the ratings
2. Near-term catalysts: JLL is benefiting from a sharp rebound in commercial real estate activity, with investment sales, debt advisory, and leasing revenues all accelerating as transaction volumes recover. On top of that, the AI boom is driving new demand for premium office space and data centers — two areas where JLL is deeply positioned to profit over the next few quarters.
3. Standout Zen Ratings: First, JLL is currently the 1st highest-rated stock in the Real Estate Service industry. The stock itself earns an A (Strong Buy) rating, putting it in a class of stocks that have historically gained 30% or more per year. Looking at the Component Grades that make up the overall grade, JLL shows balanced strength with B-grades across Value, Growth, Sentiment, and Financials, reflecting attractive valuation, solid growth prospects, positive analyst sentiment, and healthy balance sheet fundamentals. See all 7 Zen Component Grades here

2. Brink's Co (NYSE: BCO)

Famous for its bullet-resistant armored trucks, Brink's secures cash and valuables for banks, retailers, governments, and mints around the world. Now the top-rated stock in the Security & Protection Service industry, BCO just declared its quarterly dividend — and analysts project robust free cash flow growth through 2030, driven by aggressive segment expansion.

Zen Rating: A (Strong Buy) — see full analysis

Recent Price: $104.30 — get current quote

Max 1-year forecast: $163.00

Here are 3 BIG reasons why we’re watching:

1. Universal bullish sentiment among analysts: Right now, BCO enjoys 2 Strong Buy ratings and zero Hold or Sell ratings among analysts covering the stock. Truist Securities' Tobey Sommer (a top 13% rated analyst) maintains a Strong Buy rating with a $163 price target (+56.16% upside), projecting that free cash flow will rise at a 12% CAGR through FY 2030, with segment revenue growing at a 13% CAGR driven by expanding incentive compensation systems linked to segment growth. See the ratings
2. The company demonstrates exceptional growth metrics with earnings forecast to grow +96.38% in the next year and +128.62% over two years, significantly outpacing industry averages and reflecting strong operational leverage.
3. Zen Ratings likes it: BCO is currently the 1st highest-rated stock in the Security & Protection Service industry, which has an Industry Rating of B. The stock itself has an overall Zen Rating of A or Strong Buy, placing it in the top tier of the 4600+ stocks we track based on 115 fundamental checks. In terms of the Component Grades that play into the overall grade, BCO excels with an A-grade in Safety, B-grades in Value, Growth, Financials, and AI, reflecting exceptional earnings acceleration, defensive business model, attractive valuation, solid balance sheet, and technological modernization initiatives. See all 7 Zen Component Grades here

3. Tenet Healthcare Corp (NYSE: THC)

With a $15.79B market cap and a coast-to-coast network of acute care hospitals, ambulatory surgery centers, and specialty facilities, Tenet Healthcare just topped Q1 2026 earnings estimates with operational excellence and margin expansion. Even better? Shares are still trading well below their 52-week high — leaving plenty of runway ahead.

Zen Rating: B ( Buy) — see full analysis

Recent Price: $183.29 — get current quote

Max 1-year forecast: $288.00

Here are 3 BIG reasons why we’re watching:

1. Exceptionally strong analyst support: THC enjoys 10 Strong Buy ratings and 3 Buy ratings among 13 analysts, with zero Sell ratings, reflecting unanimous bullish conviction on THC's prospects. UBS's A.J. Rice (a top 11% rated analyst) maintains a Strong Buy rating with a $288 price target (+55.38% upside), the highest on the Street, citing Tenet's operational improvements and strategic positioning in key markets. See the ratings
2. The company recently enjoyed a big Q1 earnings beat, noting improving patient volumes and margin expansion trends. See earnings history here. 
3. Impressive Zen Ratings: THC currently earns a B (Buy) Zen Rating, positioning it in the upper tiers of the 4600+ stocks we track, a category where stocks have historically delivered market-beating 19.88% annual returns. The Component Grades that make up the overall grade are also strong; THC excels with B-grades in Value, Safety, and Financials, reflecting attractive valuation metrics, defensive characteristics, and solid operational fundamentals. See all 7 Zen Component Grades here

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.